Shared GHRH-receptor agonism does not mean shared, proven results
Tirzepatide, in particular, is a dual agonist, targeting both GLP-1 and GIP receptors, which can lead to even more pronounced effects
Additionally, these medications slow gastric emptying, which contributes to improved postprandial glucose control and promotes satiety, often leading to weight reduction
Other branded drugs in the GLP-1 family include Trulicity, Mounjaro and Zepbound
Yes, some
Visceral adiposity is more strongly linked to endothelial dysfunction than subcutaneous fat, making the triple-agonist mechanism particularly relevant to vascular erectile physiology